1
项与 HBI 0201-ESO TCRT 相关的临床试验A Phase I/II Dose Escalation, Safety and Efficacy Study of Anti-NY-ESO-1 T Cell Receptor (TCR)-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
A Phase I/II Dose Escalation, Safety and Efficacy Study of HBI 0201-ESO TCRT (anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes) Given by Infusion to Patients with NY-ESO-1 -Expressing Metastatic Cancers
100 项与 HBI 0201-ESO TCRT 相关的临床结果
100 项与 HBI 0201-ESO TCRT 相关的转化医学
100 项与 HBI 0201-ESO TCRT 相关的专利(医药)
100 项与 HBI 0201-ESO TCRT 相关的药物交易